METFORMIN ZENTIVA õhukese polümeerikattega tablett Estonie - estonien - Ravimiamet

metformin zentiva õhukese polümeerikattega tablett

zentiva k.s. - metformiin - õhukese polümeerikattega tablett - 500mg 500tk; 500mg 50tk; 500mg 120tk; 500mg 300tk; 500mg 60tk; 500mg 400tk; 500mg 20tk; 500mg 180tk; 500mg 56tk; 500mg 80tk; 500mg 28tk

METFORMIN ZENTIVA õhukese polümeerikattega tablett Estonie - estonien - Ravimiamet

metformin zentiva õhukese polümeerikattega tablett

zentiva k.s. - metformiin - õhukese polümeerikattega tablett - 1000mg 56tk; 1000mg 30tk; 1000mg 100tk; 1000mg 120tk; 1000mg 60tk; 1000mg 180tk; 1000mg 90tk

VILDAGLIPTIN/ METFORMIN ELVIM õhukese polümeerikattega tablett Estonie - estonien - Ravimiamet

vildagliptin/ metformin elvim õhukese polümeerikattega tablett

sia elvim - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 60tk

VILDAGLIPTIN/ METFORMIN ELVIM õhukese polümeerikattega tablett Estonie - estonien - Ravimiamet

vildagliptin/ metformin elvim õhukese polümeerikattega tablett

sia elvim - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 60tk

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Union européenne - estonien - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).

MONTELUKAST FAIR-MED 10MG õhukese polümeerikattega tablett Estonie - estonien - Ravimiamet

montelukast fair-med 10mg õhukese polümeerikattega tablett

fairmed healthcare gmbh - montelukast - õhukese polümeerikattega tablett - 10mg 100tk; 10mg 84tk; 10mg 56tk; 10mg 98tk; 10mg 200tk; 10mg 20tk; 10mg 140tk; 10mg 50tk; 10mg 90tk; 10mg 28tk; 10mg 30tk; 10mg 14tk; 10mg 7tk

Segluromet Union européenne - estonien - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

MONTELUKAST FAIR-MED 4MG närimistablett Estonie - estonien - Ravimiamet

montelukast fair-med 4mg närimistablett

fairmed healthcare gmbh - montelukast - närimistablett - 4mg 28tk; 4mg 50tk; 4mg 56tk; 4mg 200tk; 4mg 10tk; 4mg 20tk; 4mg 14tk; 4mg 7tk; 4mg 100tk

PRESTARIUM ARGININE 10MG suus dispergeeruv tablett Estonie - estonien - Ravimiamet

prestarium arginine 10mg suus dispergeeruv tablett

les laboratoires servier - perindopriil - suus dispergeeruv tablett - 10mg 500tk; 10mg 120tk; 10mg 90tk; 10mg 30tk; 10mg 50tk; 10mg 20tk; 10mg 100tk; 10mg 5tk; 10mg 60tk; 10mg 14tk; 10mg 10tk

PRESTARIUM ARGININE 5MG suus dispergeeruv tablett Estonie - estonien - Ravimiamet

prestarium arginine 5mg suus dispergeeruv tablett

les laboratoires servier - perindopriil - suus dispergeeruv tablett - 5mg 20tk; 5mg 100tk; 5mg 30tk; 5mg 90tk; 5mg 14tk; 5mg 10tk; 5mg 50tk